✦ LIBER ✦

38 – Clinical and economic outcomes of atypical antipsychotics in schizophrenia

✍ Scribed by S.V. Sonja; H.A. Nasrallah; L.S. Craigin; T.M. Baker; J. Harnett; K.N. Sanders; C. Kremer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH8: SCHIZOPHRENIA OUTCOMES RESEARCH ST

✍ J Rejas; J Bobes; M Garcia-Garcia; F Rico-Villademoros; M Madrigal; G Hernández 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Placebo-controlled clinical trials of ne

✍ P. Czobor; S. Komlosi; I. Bitter 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 129 KB

Use of typical and atypical antipsychoti

✍ N. Müller; M. Riedel; A. Schaub; B. Bondy; H.-J. Möller; M. Ackenheil 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Initiation of atypical antipsychotic age

✍ X. S. Ren; A. F. Lee; Y.-H. Huang; A. Hamed; L. Herz; D. R. Miller; L. E. Kazis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

The Impact of Newer Atypical Antipsychot

✍ Awad, A. George; Voruganti, Lakshmi N. P. 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 277 KB

Antipsychotic maintenance in schizophren

✍ J. Docherty; R. Mahmoud; A. Grogg; C. Kozma 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 254 KB